GTENMEDIUM SIGNALMANAGEMENT10-Q

GTEN updated its business combination deadline from a 24-month framework to specific dates (May 4, 2027 with potential extension to August 4, 2027), providing greater clarity on its SPAC timeline.

This change gives investors concrete dates rather than relative timeframes for when GTEN must complete its initial business combination or face liquidation. The company remains pre-revenue with no commenced operations, making the deadline timeline critical for shareholders. The specified dates suggest management is providing more definitive guidance on their M&A process timeline.

Comparing 2025-11-12 vs 2025-08-13View on EDGAR →
FINANCIAL ANALYSIS

GTEN's financial position shows modest improvement with operating losses narrowing meaningfully quarter-over-quarter, though current assets declined moderately. The company increased its total offering costs slightly to $24.2 million from $24.2 million, reflecting minor adjustments in other offering expenses. As a pre-revenue SPAC, the financial metrics remain secondary to the company's progress toward identifying and completing a business combination before its stated deadlines.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+43.8%
-$338K→-$190K

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Current Assets
Balance Sheet
-19.8%
$975K→$782K

Current assets declined 19.8% — monitor working capital adequacy and short-term liquidity.

LANGUAGE CHANGES
NEW — 2025-11-12
PRIOR — 2025-08-13
ADDED
Interim Financial Statements n Condensed Balance Sheets as of September 30, 2025 (unaudited) and December 31, 2024 3 Unaudited Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2025 and 2024 4 Unaudited Condensed Statements of Changes in Shareholders' Deficit for the Three and Nine Months Ended September 30, 2025 and 202 4 5 Unaudited Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024 7 Notes to Unaudited, Interim, Condensed Financial Statements 8 Item 2.
As of September 30, 2025, the Company had not commenced any operations.
Each Unit consists of one Class A ordinary share of the Company, par value $ 0.0001 per share (the Class A Ordinary Shares ), and one-fourth of one warrant of the Company (each, a Warrant ), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $ 11.50 per share.
Offering costs amounted to $ 24,243,141 , consisting of $ 250,000 of cash underwriting fee, $ 10,764,000 of deferred underwriting fee, $ 10,764,000 of a deferred advisory fee, and $ 2,465,141 of other offering costs.
The Company has until until May 4, 2027 (or August 4, 2027 if the Company has executed a definitive agreement for an initial Business Combination by May 4, 2027) or until such earlier liquidation date as the Company s board of directors may approve, to consummate the Company s initial business combination.
+7 more — sign up free →
REMOVED
Interim Financial Statements Condensed Balance Sheets as of June 30, 2025 (unaudited) and December 31, 2024 3 Unaudited Condensed Statements of Operations for the Three and Six Months Ended June 30, 2025 and 2024 4 Unaudited Condensed Statements of Changes in Shareholders' Deficit for the Three and Six Months Ended June 30, 2025 and 202 4 5 Unaudited Condensed Statements of Cash Flows for the Six Months Ended June 30, 2025 and 2024 6 Notes to Unaudited, Interim, Condensed Financial Statements 7 Item 2.
As of June 30, 2025, the Company had not commenced any operations.
Each Unit consists of one Class A ordinary share of the Company, par value $ 0.0001 per share (the Class A Ordinary Shares ), and one-fourth of one warrant of the Company (each, a Warrant ), with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $ 11.50 per share.Transaction costs amounted to $ 10,605,256 , consisting of $ 3,320,000 of cash underwriting fee, $ 6,640,000 of deferred underwriting fee, and $ 645,256 of other offering costs.
Offering costs amounted to $ 24,168,141 , consisting of $ 250,000 of cash underwriting fee, $ 10,764,000 of deferred underwriting fee, $ 10,764,000 of a deferred advisory fee, and $ 2,390,141 of other offering costs.
The Company has until the date that is 24 months from the closing of the IPO (or 27 months from the closing of the IPO if the Company has executed a definitive agreement for an initial Business Combination within 24 months from the closing of the IPO) or until such earlier liquidation date as the Company s board of directors may approve, to consummate the Company s initial business combination.
+7 more — sign up free →
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →